Search for Clinical Trial Results

Sponsored By

Primary Agammaglobulinemia - 4 Studies Found

Status Study
Completed Study Name: A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody Deficiency
Condition: Primary or Secondary Antibody Deficiency (PAD or SAD).
Date: 2014-09-02
Interventions: Biological: Vigam® (Human Normal Immunoglobulin)
Recruiting Study Name: Polysaccharide Antibody Response Study
Condition: Specific Polysaccharide Antibody Deficiency
Date: 2015-02-19
Interventions:
  • Biological: Pneumovax 23 (Sanofi Pasteur MSD)

Completed Study Name: Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
Condition: Primary Immune Deficiency Disorder
Date: 2013-03-06
Interventions: Biological: RI-002 Immune Globulin Intravenous (IGIV)
Completed Study Name: Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)
Condition: Primary Immune Deficiency Disorders (PIDD)
Date: 2007-10-01
Interventions: Biological: Nabi-IGIV 10% [Immune Globulin Intravenous (Human). 10%] Nabi-IGIV 10% [Immune Globulin Intr